AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22853818 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous artesunate (AS) 4 mg/kg
Number of subjects: 24
Study 22853818 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous artesunate (AS) 8 mg/kg
Number of subjects: 24
Study 20159049 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus salivarius CECT5713 (2 x 10(8) CFU daily for 4 weeks)
Number of subjects: 40
Study 17934817 — intervention group
Group type: EXPERIMENTAL
Intervention: PHQ-9
Number of subjects: 129
Study 17934817 — intervention group
Group type: EXPERIMENTAL
Intervention: BDI-II
Number of subjects: 129
Study 17934817 — intervention group
Group type: EXPERIMENTAL
Intervention: CES-D
Number of subjects: 129
Study 15740629 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking two cigarettes
Number of subjects: 16
Study 15740629 — intervention group
Group type: COMPARATOR
Intervention: Non-smoking
Number of subjects: 16
Study 12232452 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin (1 mg/kg/dose, subcutaneous, twice daily)
Number of subjects: 59
Study 12232452 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (adjusted dose, intravenous)
Number of subjects: 59
Study 12232452 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 59
Study 10424385 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of mercury vapour (0.6-10 microg)
Number of subjects: 39
Study 10424385 — intervention group
Group type: COMPARATOR
Intervention: Inhalation of pure air
Number of subjects: 39
Study 10424385 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of mercury vapour
Number of subjects: 39
Study 7547611 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorting cards into two piles whilst saying the colour of the card aloud
Number of subjects: 16
Study 7547611 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading aloud
Number of subjects: 16
Study 7547611 — intervention group
Group type: COMPARATOR
Intervention: Sorting cards quietly into one, two, four, 13 and 26 piles
Number of subjects: 16
Study 2188766 — intervention group
Group type: EXPERIMENTAL
Intervention: Flosequinan
Number of subjects: 17
Study 2188766 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 7386840 — intervention group
Group type: EXPERIMENTAL
Intervention: Minaxolone
Number of subjects: 100
Study 7386840 — intervention group
Group type: EXPERIMENTAL
Intervention: Minaxolone with fentanyl
Number of subjects: 100
Study 7386840 — intervention group
Group type: COMPARATOR
Intervention: Control group (Minaxolone without fentanyl)
Number of subjects: 100
Study 31630567 — intervention group
Group type: EXPERIMENTAL
Intervention: Response adaptive randomization with maintained control allocation
Number of subjects: 0
Study 31630567 — intervention group
Group type: EXPERIMENTAL
Intervention: Response adaptive randomization with increased control allocation
Number of subjects: 0
Study 31630567 — intervention group
Group type: EXPERIMENTAL
Intervention: Response adaptive randomization with variable control allocation
Number of subjects: 0
Study 31108818 — intervention group
Group type: EXPERIMENTAL
Intervention: Triangular WL 'High in/Alto em' (Alto)
Number of subjects: 2419
Study 31108818 — intervention group
Group type: EXPERIMENTAL
Intervention: Triangular WL 'A lot of/Muito' (Muito)
Number of subjects: 2419
Study 31108818 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no WL)
Number of subjects: 2419
Study 28880260 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 932
Study 28880260 — intervention group
Group type: COMPARATOR
Intervention: Open-label steroid therapy
Number of subjects: 932
Study 26341755 — intervention group
Group type: EXPERIMENTAL
Intervention: Romiplostim
Number of subjects: 159
Study 26341755 — intervention group
Group type: COMPARATOR
Intervention: Placebo/SOC
Number of subjects: 159
Study 22831916 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month physical activity behavior change intervention (supervised aerobic exercise of 150 weekly minutes at moderate intensity and resistance exercise 2 sessions per week)
Number of subjects: 28
Study 22831916 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month physical activity behavior change intervention
Number of subjects: 28
Study 22831916 — intervention group
Group type: COMPARATOR
Intervention: usual care group (UCG)
Number of subjects: 28
Study 21407090 — intervention group
Group type: EXPERIMENTAL
Intervention: Transparent dressings
Number of subjects: 0
Study 21407090 — intervention group
Group type: COMPARATOR
Intervention: Gauze dressings
Number of subjects: 0
Study 19884576 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta (IFNbeta) in patients with preserved bioactivity (n = 8)
Number of subjects: 15
Study 19884576 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta (IFNbeta) in patients with lost bioactivity (n = 7)
Number of subjects: 15
Study 17710587 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g/day pressurized whey protein
Number of subjects: 36
Study 17710587 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g/day pressurized whey protein
Number of subjects: 36
Study 17710587 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 g/day pressurized whey protein
Number of subjects: 36
Study 15296210 — intervention group
Group type: EXPERIMENTAL
Intervention: Commonly used foot orthosis materials
Number of subjects: 10
Study 11525226 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervitec varnish containing 1% chlorhexidine (CHx) applied at baseline, 3-4 months, and 6 months.
Number of subjects: 200
Study 11525226 — intervention group
Group type: COMPARATOR
Intervention: Control group received prophylaxis using cotton pellet in water.
Number of subjects: 200
Study 11525226 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervitec varnish containing 1% chlorhexidine (CHx).
Number of subjects: 200
Study 11076449 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional relaxation technique
Number of subjects: 12
Study 11076449 — intervention group
Group type: COMPARATOR
Intervention: Placebo-relaxation technique (control)
Number of subjects: 12
Study 9228724 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkali citrate
Number of subjects: 0
Study 9228724 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 0
Study 9228724 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiazides
Number of subjects: 0
Study 9228724 — intervention group
Group type: EXPERIMENTAL
Intervention: High fluid intake and sensible diet
Number of subjects: 0
Study 1326318 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/m2 body surface ACTH4-9 analog before and after each cisplatin cycle
Number of subjects: 0
Study 1326318 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3904337 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 174
Study 3904337 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study 30882166 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm solution (37 degrees)
Number of subjects: 60
Study 30882166 — intervention group
Group type: COMPARATOR
Intervention: Cold fluid (20 degrees)
Number of subjects: 60
Study 30882166 — intervention group
Group type: COMPARATOR
Intervention: Room temperature fluid (24 degrees)
Number of subjects: 60
Study 30058112 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg/day
Number of subjects: 2186
Study 30058112 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2186
Study 27098452 — intervention group
Group type: EXPERIMENTAL
Intervention: Textured insole (n=88)
Number of subjects: 176
Study 27098452 — intervention group
Group type: COMPARATOR
Intervention: Smooth control insole (n=88)
Number of subjects: 176
Study 25216464 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped Care Program (SCP)
Number of subjects: 240
Study 25216464 — intervention group
Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 240
Study 22646082 — intervention group
Group type: EXPERIMENTAL
Intervention: ABA-based therapy sessions (2-3 sessions per week for 1 year)
Number of subjects: 4
Study 22646082 — intervention group
Group type: COMPARATOR
Intervention: Control group (matched children with AS)
Number of subjects: 4
Study 19864941 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte-containing, buffy-coat-depleted red blood cells
Number of subjects: 346
Study 19864941 — intervention group
Group type: COMPARATOR
Intervention: Leukocyte-depleted red blood cells
Number of subjects: 346
Study 17571741 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogic practices (specifics on dosage and duration not available)
Number of subjects: 0
Study 17571741 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogic practices
Number of subjects: 0
Study 15661814 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening samples (after activation with specific TLR ligands)
Number of subjects: 19
Study 15661814 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-exercise samples (after activation with specific TLR ligands)
Number of subjects: 19
Study 15661814 — intervention group
Group type: COMPARATOR
Intervention: Rest samples (before exercise)
Number of subjects: 19
Study 11953038 — intervention group
Group type: EXPERIMENTAL
Intervention: CMV-specific T cell therapy
Number of subjects: 0
Study 11953038 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 10440303 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational therapy intervention for up to 5 months at home
Number of subjects: 185
Study 10440303 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 185
Study 7757046 — intervention group
Group type: EXPERIMENTAL
Intervention: Operant treatment
Number of subjects: 71
Study 7757046 — intervention group
Group type: EXPERIMENTAL
Intervention: Operant-cognitive treatment (OC)
Number of subjects: 71
Study 7757046 — intervention group
Group type: EXPERIMENTAL
Intervention: Operant-respondent treatment (OR)
Number of subjects: 71
Study 7757046 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 71
Study 2148326 — intervention group
Group type: EXPERIMENTAL
Intervention: dextroamphetamine (d‐AMPH)
Number of subjects: 0
Study 2148326 — intervention group
Group type: EXPERIMENTAL
Intervention: desipramine
Number of subjects: 0
Study 2148326 — intervention group
Group type: EXPERIMENTAL
Intervention: alprazolam
Number of subjects: 0
Study 2148326 — intervention group
Group type: EXPERIMENTAL
Intervention: desipramine‐alprazolam combination
Number of subjects: 0
Study 31970830 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital-family holistic care model based on 'Timing It Right'
Number of subjects: 119
Study 31970830 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine care and follow-up)
Number of subjects: 119
Study 30932653 — intervention group
Group type: EXPERIMENTAL
Intervention: Kerr beam self-cleaning
Number of subjects: 0
Study 30932653 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct and inverse cascade towards high mode numbers
Number of subjects: 0
Study 27866347 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity resistance training with heating sheet (HRT group)
Number of subjects: 21
Study 27866347 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity resistance training (RT group)
Number of subjects: 21
Study 27866347 — intervention group
Group type: COMPARATOR
Intervention: Heating sheet only (HEAT group)
Number of subjects: 21
Study 25562579 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care intervention (cognitive-behavioral therapy and/or pharmacotherapy)
Number of subjects: 1004
Study 25562579 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 1004
Study 23995765 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in joint space width (JSW) over 3 years
Number of subjects: 133
Study 23995765 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in WOMAC score over 3 years
Number of subjects: 133
Study 23995765 — intervention group
Group type: EXPERIMENTAL
Intervention: JSW and WOMAC score changes included in the same model
Number of subjects: 133
Study 23995765 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee replacement occurrence
Number of subjects: 133
Study 22409097 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 100
Study 22409097 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no CBT)
Number of subjects: 100
Study 19133917 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 2184
Study 17045352 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL-A (new equation using total cholesterol and triglycerides)
Number of subjects: 230
Study 17045352 — intervention group
Group type: COMPARATOR
Intervention: LDL-F (Friedewald formula)
Number of subjects: 230
Study 15325679 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat vegan diet
Number of subjects: 59
Study 15325679 — intervention group
Group type: COMPARATOR
Intervention: Step II diet
Number of subjects: 59
Study 11554424 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine HCl oral sustained-release dosage form
Number of subjects: 6
Study 11554424 — intervention group
Group type: COMPARATOR
Intervention: Cardene SR
Number of subjects: 6
Study 9456565 — intervention group
Group type: EXPERIMENTAL
Intervention: no‐RROP
Number of subjects: 100
Study 9456565 — intervention group
Group type: COMPARATOR
Intervention: RROP
Number of subjects: 100
Study 8166894 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 0
Study 8166894 — intervention group
Group type: EXPERIMENTAL
Intervention: Prilocaine
Number of subjects: 0
Study 8166894 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study 8166894 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including bupivacaine, prilocaine, and control)
Number of subjects: 0
Study 2459516 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin (up to a dose of 10 mg)
Number of subjects: 0
Study 2459516 — intervention group
Group type: EXPERIMENTAL
Intervention: Phentolamine
Number of subjects: 0
Study 2459516 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritanserin
Number of subjects: 0
Study 2459516 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of phentolamine and ritanserin
Number of subjects: 0
Study 2459516 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 0
Study 30185106 — intervention group
Group type: EXPERIMENTAL
Intervention: Position on mother's abdomen (Group AL)
Number of subjects: 199
Study 30185106 — intervention group
Group type: COMPARATOR
Intervention: Position 20 cm below the introitus (Group BL)
Number of subjects: 199
Study 30185106 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 199
Study 30553077 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-delivered cognitive behavioral therapy (T-CBT)
Number of subjects: 160
Study 30553077 — intervention group
Group type: COMPARATOR
Intervention: Telephone-delivered pain psychoeducational active control condition (T-Ed)
Number of subjects: 160
Study 26965476 — intervention group
Group type: EXPERIMENTAL
Intervention: Teachers' Diploma Programme on Psychosocial Care, Support, and Protection (15-month long-distance learning program)
Number of subjects: 325
Study 26210752 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib
Number of subjects: 202
Study 26210752 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study 23739564 — intervention group
Group type: EXPERIMENTAL
Intervention: AutoFlow with SIMV
Number of subjects: 48
Study 23739564 — intervention group
Group type: COMPARATOR
Intervention: Control group (SIMV only)
Number of subjects: 48
Study 23739564 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation group (AutoFlow with SIMV)
Number of subjects: 48
Study 21354122 — intervention group
Group type: EXPERIMENTAL
Intervention: Bezafibrate (400 mg daily)
Number of subjects: 2
Study 21354122 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg daily)
Number of subjects: 2
Study 18637324 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive counselling including use of feeding cups and showing pictures of severe early childhood caries and a dental model at four, six, nine, and 12 month visits.
Number of subjects: 132
Study 18637324 — intervention group
Group type: COMPARATOR
Intervention: Brief counselling on the use of a feeding cup at 6 months and bottle weaning at nine and 12 months without photographs or dental models.
Number of subjects: 132
Study 16010453 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural mineral water with high mineral content
Number of subjects: 6
Study 16010453 — intervention group
Group type: COMPARATOR
Intervention: Control (natural mineral water with low mineral content)
Number of subjects: 6
Study 12967481 — intervention group
Group type: EXPERIMENTAL
Intervention: M-CSF administered group (group 1; 19 patients)
Number of subjects: 39
Study 12967481 — intervention group
Group type: COMPARATOR
Intervention: Non-M-CSF administered group (group 2; 20 patients)
Number of subjects: 39
Study 12967481 — intervention group
Group type: EXPERIMENTAL
Intervention: M-CSF + G-CSF group
Number of subjects: 39
Study 10882962 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 180
Study 10882962 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 10882962 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 180
Study 8885185 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical audit and feedback in study hospitals
Number of subjects: 2593
Study 8885185 — intervention group
Group type: COMPARATOR
Intervention: Control hospital
Number of subjects: 2593
Study 1382623 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone 30 mg/kg body weight 1 1/2 hours before, and four and 12 hours after operation (n = 6)
Number of subjects: 12
Study 1382623 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 6)
Number of subjects: 12
Study 1382623 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone group (n = 6)
Number of subjects: 12
Study 4005083 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect blood pressure measurement using a random zero sphygmomanometer
Number of subjects: 25
Study 4005083 — intervention group
Group type: COMPARATOR
Intervention: Intra-arterial blood pressure measurement using the Oxford system
Number of subjects: 25
Study 4005083 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-exercise blood pressure measurement
Number of subjects: 25
Study 4005083 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic and diastolic blood pressure measurements during exercise
Number of subjects: 25
Study 31821491 — intervention group
Group type: COMPARATOR
Intervention: Technique inspection
Number of subjects: 150
Study 31821491 — intervention group
Group type: COMPARATOR
Intervention: Oral education
Number of subjects: 150
Study 31821491 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 150
Study 29427368 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir
Number of subjects: 54
Study 29427368 — intervention group
Group type: COMPARATOR
Intervention: Adefovir
Number of subjects: 54
Study 29427368 — intervention group
Group type: EXPERIMENTAL
Intervention: ALT flare
Number of subjects: 54
Study 28437308 — intervention group
Group type: EXPERIMENTAL
Intervention: ShotBlocker
Number of subjects: 100
Study 28437308 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 100
Study 26317254 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with AAA and ILT
Number of subjects: 157
Study 26317254 — intervention group
Group type: COMPARATOR
Intervention: Patients with AAA without ILT
Number of subjects: 157
Study 22882018 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) 800 mg once-daily for 12 weeks
Number of subjects: 1049
Study 22882018 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) 1200 mg once-daily for 12 weeks
Number of subjects: 1049
Study 22882018 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1049
Study 21247561 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Uchida technique
Number of subjects: 2198
Study 21247561 — intervention group
Group type: COMPARATOR
Intervention: Silver clips
Number of subjects: 2198
Study 18436169 — intervention group
Group type: EXPERIMENTAL
Intervention: Allevyn foam
Number of subjects: 60
Study 18436169 — intervention group
Group type: COMPARATOR
Intervention: Jellonet with proflavin-soaked cotton wool
Number of subjects: 60
Study 16956332 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic colposuspension
Number of subjects: 291
Study 16956332 — intervention group
Group type: COMPARATOR
Intervention: Open colposuspension
Number of subjects: 291
Study 15294385 — intervention group
Group type: EXPERIMENTAL
Intervention: BDI-high normal group
Number of subjects: 52
Study 15294385 — intervention group
Group type: EXPERIMENTAL
Intervention: BDI-low group
Number of subjects: 52
Study 15294385 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study 11280555 — intervention group
Group type: EXPERIMENTAL
Intervention: Alosetron 1 mg b.i.d. for 48 weeks
Number of subjects: 859
Study 11280555 — intervention group
Group type: COMPARATOR
Intervention: Placebo b.i.d. for 48 weeks
Number of subjects: 859
Study 11280555 — intervention group
Group type: EXPERIMENTAL
Intervention: Alosetron 1 mg b.i.d.
Number of subjects: 859
Study 11280555 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 859
Study 9308791 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh testicular spermatozoa (ICSI)
Number of subjects: 20
Study 9308791 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen-thawed testicular spermatozoa (ICSI)
Number of subjects: 20
Study 9308791 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh testicular spermatozoa from non-obstructive azoospermia (ICSI)
Number of subjects: 20
Study 9308791 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultured testicular spermatozoa from obstructive azoospermia
Number of subjects: 20
Study 9308791 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultured testicular spermatozoa from non-obstructive azoospermia
Number of subjects: 20
Study 8316770 — intervention group
Group type: EXPERIMENTAL
Intervention: Different training programs
Number of subjects: 75